Trial Profile
Phase IIb double blinded parallel group dose response study for DVC1-0101 to treat severe intermittent claudication
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs DVC1 0101 (Primary)
- Indications Intermittent claudication
- Focus Therapeutic Use
- 16 May 2016 New trial record